Evidence map›Paper›PMID 41989376›Full record

ArticleJACC. Advances2026

Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes in Peripartum Cardiomyopathy.

Hritvik Jain, Nandan Patel, Jyoti Jain, Omar Baqal, Christopher V DeSimone, Andrew M Goldsweig, Joanna M Joly, Robert J Mentz, Gregg C Fonarow, Garima Sharma

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hritvik JainDepartment of Medicine, All India Institute of Medical Sciences, Jodhpur, India.
Nandan PatelDepartment of Medicine, All India Institute of Medical Sciences, Jodhpur, India.
Jyoti JainDepartment of Internal Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
Omar BaqalDepartment of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA.
Christopher V DeSimoneDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Andrew M GoldsweigDepartment of Cardiovascular Medicine, Baystate Medical Center and Division of Cardiovascular Medicine, University of Massachusetts-Baystate, Springfield, Massachusetts, USA.
Joanna M JolyDepartment of Cardiology, Inova Schar Heart and Vascular Institute, Inova Health System, Falls Church, Virginia, USA.
Robert J MentzDuke University Medical Center, Division of Cardiology, Durham, North Carolina, USA; Duke Clinical Research Institute, Durham, North Carolina, USA.
Gregg C FonarowAhmanson-UCLA Cardiomyopathy Center, Division of Cardiology, Department of Medicine, University of California, Los Angeles, California, USA.
Garima SharmaDepartment of Cardiology, Inova Schar Heart and Vascular Institute, Inova Health System, Falls Church, Virginia, USA. Electronic address: Garima.Sharma@inova.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

guideline-directed medical therapyheart failureperipartum cardiomyopathySGLT2isodium glucose co-transporter 2 inhibitors

Identifiers

PMID41989376
PMCPMC13309337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.